|
CV Information
 DR. RUZILAWATI BINTI ABU BAKAR
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | GRADUATE DEVELOPMENT INCENTIVE - PHD, "DEVELOPMENT AND VALIDATION OF LC-MS/MS METHOD FOR THE DETERMINATION OF COLISTIN AND COLISTIN METHANESULFONATE (CMS) AND ITS APPLICATION FOR PLASMA-SAMPLE OF CRITICALLY ILL PATIENTS" (01.05.2020 - 30.04.2022) (Principal) [ TABUNG PPSP ] - Source: eR&I |
| 2 | RESEARCH UNIVERSITY (INDIVIDUAL), "STUDY ON THE SERUM AND GENE EXPRESSION PROFILE OF CYTOKINES INVOLVED IN HEPATITIS C INFECTION AND THE ROLE OF CYTOKINE GENE POLYMORPHISM ON SUSCEPTIBILITY TO INFECTION AMONG DRUG ABUSERS" (01.06.2018 - 31.05.2021) (Principal) [ USM (RU) ] - Source: eR&I |
| 3 | SHORT TERM - ACADEMIC STAFF, "DEVELOPMENT OF HIGH RESOLUTION MELTING (HRM) METHODS TO DETECT DAPOMINE TRANSPOTER (SLC6A3) GENE POLYMORPHISMS AND ITS RELATIONSHIP TO SMOKING BEHAVIOR AMONG MALAY MALE SUBJECTS" (01.09.2014 - 31.08.2016) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
| 4 | SHORT TERM - ACADEMIC STAFF, "METHOD DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) FOR DETERMINATION OF MORPHINE IN HUMAN URINE" (01.11.2010 - 31.10.2012) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
| 5 | INCENTIVE GRANT, "METHOD DEVELOPMENT OF CYP3A4*1B, CYP3A4*2 AND CYP3A4*6 GENETIC POLYMORPHISMS" (14.05.2009 - 13.05.2010) (Principal) [ USM (INSENTIF) ] - Source: eR&I |
| 6 | , "EVALUATION OF DOPAMINE RECEPTOR MRNA EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES OF AMPHETAMINE TYPE STIMULANT & OPIOID DEPENDENT MALAY MEN" (01.04.2018 - 31.10.2018) [ PPSP USM ] - Source: HCMSv3 |
| 7 | , "GENETIC POLYMORPHISM OF DOPAMINE β-HYDROXYLASE AND NOREPINEPHRINE TRANSPORTER GENE POLYMORPHISMS IN MALAY MALE SUBJECTS WITH CO-OCCURING AMPHETAMINE-TYPE SIMULANT AND OPIOID DEPENDENCE IN KOTA BHARU, KELANTAN" (01.08.2017 - 31.10.2017) [ UNIVERSITI SAINS MALAYSIA ] - Source: HCMSv3 |